Literature DB >> 33531085

COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020.

Eduardo A Undurraga1,2, Gerardo Chowell3, Kenji Mizumoto4,5.   

Abstract

BACKGROUND: Early severity estimates of coronavirus disease 2019 (COVID-19) are critically needed to assess the potential impact of the ongoing pandemic in different demographic groups. Here we estimate the real-time delay-adjusted case fatality rate across nine age groups by gender in Chile, the country with the highest testing rate for COVID-19 in Latin America.
METHODS: We used a publicly available real-time daily series of age-stratified COVID-19 cases and deaths reported by the Ministry of Health in Chile from the beginning of the epidemic in March through August 31, 2020. We used a robust likelihood function and a delay distribution to estimate real-time delay-adjusted case-fatality risk and estimate model parameters using a Monte Carlo Markov Chain in a Bayesian framework.
RESULTS: As of August 31, 2020, our estimates of the time-delay adjusted case fatality rate (CFR) for men and women are 4.16% [95% Credible Interval (CrI): 4.09-4.24%] and 3.26% (95% CrI: 3.19-3.34%), respectively, while the overall estimate is 3.72% (95% CrI: 3.67-3.78%). Seniors aged 80 years and over have an adjusted CFR of 56.82% (95% CrI: 55.25-58.34%) for men and 41.10% (95% CrI: 40.02-42.26%) for women. Results showed a peak in estimated CFR during the June peak of the epidemic. The peak possibly reflects insufficient laboratory capacity, as illustrated by high test positivity rates (33% positive 7-day average nationally in June), which may have resulted in lower reporting rates.
CONCLUSIONS: Severity estimates from COVID-19 in Chile suggest that male seniors, especially among those aged ≥ 70 years, are being disproportionately affected by the pandemic, a finding consistent with other regions. The ongoing pandemic is imposing a high death toll in South America, and Chile has one of the highest reported mortality rates globally thus far. These real-time estimates may help inform public health officials' decisions in the region and underscore the need to implement more effective measures to ameliorate fatality.

Entities:  

Keywords:  COVID-19; Chile; Death risk by age group; Latin America; Time-delay adjusted case fatality rate

Year:  2021        PMID: 33531085     DOI: 10.1186/s40249-020-00785-1

Source DB:  PubMed          Journal:  Infect Dis Poverty        ISSN: 2049-9957            Impact factor:   4.520


  33 in total

1.  Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil.

Authors:  William Marciel de Souza; Lewis Fletcher Buss; Darlan da Silva Candido; Jean-Paul Carrera; Sabrina Li; Alexander E Zarebski; Rafael Henrique Moraes Pereira; Carlos A Prete; Andreza Aruska de Souza-Santos; Kris V Parag; Maria Carolina T D Belotti; Maria F Vincenti-Gonzalez; Janey Messina; Flavia Cristina da Silva Sales; Pamela Dos Santos Andrade; Vítor Heloiz Nascimento; Fabio Ghilardi; Leandro Abade; Bernardo Gutierrez; Moritz U G Kraemer; Carlos K V Braga; Renato Santana Aguiar; Neal Alexander; Philippe Mayaud; Oliver J Brady; Izabel Marcilio; Nelson Gouveia; Guangdi Li; Adriana Tami; Silvano Barbosa de Oliveira; Victor Bertollo Gomes Porto; Fabiana Ganem; Walquiria Aparecida Ferreira de Almeida; Francieli Fontana Sutile Tardetti Fantinato; Eduardo Marques Macário; Wanderson Kleber de Oliveira; Mauricio L Nogueira; Oliver G Pybus; Chieh-Hsi Wu; Julio Croda; Ester C Sabino; Nuno Rodrigues Faria
Journal:  Nat Hum Behav       Date:  2020-07-31

2.  Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.

Authors:  Seth Flaxman; Swapnil Mishra; Axel Gandy; H Juliette T Unwin; Thomas A Mellan; Helen Coupland; Charles Whittaker; Harrison Zhu; Tresnia Berah; Jeffrey W Eaton; Mélodie Monod; Azra C Ghani; Christl A Donnelly; Steven Riley; Michaela A C Vollmer; Neil M Ferguson; Lucy C Okell; Samir Bhatt
Journal:  Nature       Date:  2020-06-08       Impact factor: 49.962

3.  COVID-19 in Latin America.

Authors:  Talha Burki
Journal:  Lancet Infect Dis       Date:  2020-04-17       Impact factor: 25.071

4.  South America prepares for the impact of COVID-19.

Authors:  Tony Kirby
Journal:  Lancet Respir Med       Date:  2020-04-29       Impact factor: 30.700

5.  COVID-19 Response in Latin America.

Authors:  Patricia J Garcia; Alex Alarcón; Angela Bayer; Paulo Buss; German Guerra; Helena Ribeiro; Karol Rojas; Rocío Saenz; Nelly Salgado de Snyder; Giorgio Solimano; Rubén Torres; Sebastián Tobar; Rafael Tuesca; Gilma Vargas; Rifat Atun
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

6.  Political and institutional perils of Brazil's COVID-19 crisis.

Authors:  Lorena G Barberia; Eduardo J Gómez
Journal:  Lancet       Date:  2020-07-30       Impact factor: 79.321

7.  COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin America: Pushing strained health care systems over the edge.

Authors:  Juan-Carlos Navarro; Jazzmin Arrivillaga-Henríquez; José Salazar-Loor; Alfonso J Rodriguez-Morales
Journal:  Travel Med Infect Dis       Date:  2020-04-05       Impact factor: 6.211

Review 8.  Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.

Authors:  Sasmita Poudel Adhikari; Sha Meng; Yu-Ju Wu; Yu-Ping Mao; Rui-Xue Ye; Qing-Zhi Wang; Chang Sun; Sean Sylvia; Scott Rozelle; Hein Raat; Huan Zhou
Journal:  Infect Dis Poverty       Date:  2020-03-17       Impact factor: 4.520

9.  Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality.

Authors:  William Morgenlander; Stephanie Henson; Daniel Monaco; Athena Chen; Kirsten Littlefield; Evan M Bloch; Eric Fujimura; Ingo Ruczinski; Andrew R Crowley; Harini Natarajan; Savannah E Butler; Joshua A Weiner; Mamie Z Li; Tania S Bonny; Sarah E Benner; David Sullivan; Shmuel Shoham; Thomas C Quinn; Susan Eshleman; Arturo Casadevall; Andrew D Redd; Oliver Laeyendecker; Margaret E Ackerman; Andrew Pekosz; Stephen J Elledge; Matthew Robinson; Aaron A R Tobian; H Benjamin Larman
Journal:  medRxiv       Date:  2020-12-18

10.  The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries.

Authors:  Patrick G T Walker; Charles Whittaker; Oliver J Watson; Marc Baguelin; Peter Winskill; Arran Hamlet; Bimandra A Djafaara; Zulma Cucunubá; Daniela Olivera Mesa; Will Green; Hayley Thompson; Shevanthi Nayagam; Kylie E C Ainslie; Sangeeta Bhatia; Samir Bhatt; Adhiratha Boonyasiri; Olivia Boyd; Nicholas F Brazeau; Lorenzo Cattarino; Gina Cuomo-Dannenburg; Amy Dighe; Christl A Donnelly; Ilaria Dorigatti; Sabine L van Elsland; Rich FitzJohn; Han Fu; Katy A M Gaythorpe; Lily Geidelberg; Nicholas Grassly; David Haw; Sarah Hayes; Wes Hinsley; Natsuko Imai; David Jorgensen; Edward Knock; Daniel Laydon; Swapnil Mishra; Gemma Nedjati-Gilani; Lucy C Okell; H Juliette Unwin; Robert Verity; Michaela Vollmer; Caroline E Walters; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; David G Lalloo; Neil M Ferguson; Azra C Ghani
Journal:  Science       Date:  2020-06-12       Impact factor: 47.728

View more
  34 in total

1.  SARS-CoV-2 prevalence at eight urban health clinics in Nicaragua: possible implications for the COVID-19 pandemic.

Authors:  Jorge A Huete-Pérez; Robert C Colgrove; Cristiana Cabezas-Robelo; Lucía Páiz-Medina; Bhanasut Hunsajarupan; Sheyla Silva; Carlos Quant; Alejandra Huete
Journal:  IJID Reg       Date:  2022-01-05

2.  Assessing relative COVID-19 mortality: a Swiss population-based study.

Authors:  Torsten Hothorn; Matthias Bopp; Huldrych Günthard; Olivia Keiser; Maroussia Roelens; Caroline E Weibull; Michael Crowther
Journal:  BMJ Open       Date:  2021-03-08       Impact factor: 2.692

3.  Potential Genes Associated with COVID-19 and Comorbidity.

Authors:  Shanshan Feng; Fuqiang Song; Wenqiong Guo; Jishan Tan; Xianqin Zhang; Fengling Qiao; Jinlin Guo; Lin Zhang; Xu Jia
Journal:  Int J Med Sci       Date:  2022-01-24       Impact factor: 3.738

4.  Utility of Age-adjusted Charlson Comorbidity Index as a Predictor of Need for Invasive Mechanical Ventilation, Length of Hospital Stay, and Survival in COVID-19 Patients.

Authors:  Vishal Shanbhag; N R Arjun; Souvik Chaudhuri; Akhilesh K Pandey
Journal:  Indian J Crit Care Med       Date:  2021-09

5.  Delay-Adjusted Age-Specific COVID-19 Case Fatality Rates in a High Testing Setting: South Korea, February 2020 to February 2021.

Authors:  Eunha Shim
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

6.  PM2.5 Pollution Strongly Predicted COVID-19 Incidence in Four High-Polluted Urbanized Italian Cities during the Pre-Lockdown and Lockdown Periods.

Authors:  Ourania S Kotsiou; Vaios S Kotsios; Ioannis Lampropoulos; Thomas Zidros; Sotirios G Zarogiannis; Konstantinos I Gourgoulianis
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

Review 7.  Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies.

Authors:  Hakimeh Baghaei Daemi; Muhammad Fakhar-E-Alam Kulyar; Xinlin He; Chengfei Li; Morteza Karimpour; Xiaomei Sun; Zhong Zou; Meilin Jin
Journal:  Viruses       Date:  2021-06-15       Impact factor: 5.048

8.  Meta-analysis and adjusted estimation of COVID-19 case fatality risk in India and its association with the underlying comorbidities.

Authors:  Balbir B Singh; Michael P Ward; Mark Lowerison; Ryan T Lewinson; Isabelle A Vallerand; Rob Deardon; Jatinder P S Gill; Baljit Singh; Herman W Barkema
Journal:  One Health       Date:  2021-06-25

9.  Benchmarking the Covid-19 pandemic across countries and states in the USA under heterogeneous testing.

Authors:  Kenzo Asahi; Eduardo A Undurraga; Rodrigo Wagner
Journal:  Sci Rep       Date:  2021-07-26       Impact factor: 4.379

Review 10.  Severe acute respiratory syndrome coronavirus-2: implications for blood safety and sufficiency.

Authors:  Philip Kiely; Veronica C Hoad; Clive R Seed; Iain B Gosbell
Journal:  Vox Sang       Date:  2020-09-23       Impact factor: 2.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.